Stromal deactivation by CSF1: a new feature of the aggressive pancreatic cancer microenvironment.


Journal

EMBO reports
ISSN: 1469-3178
Titre abrégé: EMBO Rep
Pays: England
ID NLM: 100963049

Informations de publication

Date de publication:
06 05 2020
Historique:
pubmed: 25 4 2020
medline: 27 10 2020
entrez: 25 4 2020
Statut: ppublish

Résumé

Pancreatic ductal adenocarcinoma (PDAC) is an aggressive cancer with one of the poorest prognosis among all malignancies. The initiation and evolution of this kind of tumor depends on a complex interaction between cancer cells and the tumor microenvironment (TME). In an elegant study, Steins et al [1] used a combination of relevant disease models to show that mesenchymal subtype of PDAC shows a distinct deactivation of stellate cells in a CSF1-dependent fashion. This study shedding light on a new role for the stroma driving an aggressive PDAC subtypes shifts the current paradigm for the requirement of an activated TME to regulate PDAC growth and maintenance.

Identifiants

pubmed: 32329185
doi: 10.15252/embr.202050468
pmc: PMC7202212
doi:

Substances chimiques

Macrophage Colony-Stimulating Factor 81627-83-0

Types de publication

News Comment

Langues

eng

Sous-ensembles de citation

IM

Pagination

e50468

Commentaires et corrections

Type : CommentOn

Informations de copyright

© 2020 The Authors.

Références

Ann Gastroenterol Surg. 2019 Jan 04;3(2):130-137
pubmed: 30923782
EMBO Rep. 2020 May 6;21(5):e50468
pubmed: 32329185
EMBO Rep. 2020 May 6;21(5):e48780
pubmed: 32173982
Pflugers Arch. 2017 Sep;469(9):1039-1050
pubmed: 28382480
Nat Rev Cancer. 2016 Aug 23;16(9):582-98
pubmed: 27550820
World J Gastroenterol. 2018 Nov 21;24(43):4846-4861
pubmed: 30487695
Front Physiol. 2012 Aug 28;3:344
pubmed: 22973234

Auteurs

Renzo E Vera (RE)

Schulze Center of Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.

Martin E Fernandez-Zapico (ME)

Schulze Center of Novel Therapeutics, Division of Oncology Research, Mayo Clinic, Rochester, MN, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH